Avatar photo

Ron Finklestien

5 Bitcoin-Centric Stocks to Buy to Gain From the Next Rally

The cryptocurrency market suffered a severe blow in April after a strong rally in the previous 15 months. On Mar 14, the largest cryptocurrency, ...

3 Steel Producer Stocks to Escape Industry Headwinds

The Zacks Steel Producers industry has lost momentum after enjoying a strong recovery during the final quarter of 2023 as steel prices have come ...

Take the Zacks Approach to Beat the Markets: Goldman Sachs, Rush Street Interactive, Atmus Filtration Technologies in Focus

Last week, major U.S. indexes, the S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average, gained marginally by 1.6%, 1.8% and 1.4%, ...

Wix.com (WIX) Q1 Earnings and Revenues Top Estimates

Wix.com (WIX) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings ...

Time to Reassess Exit, Stop-Loss Points

““If you are aggressive and anticipate the SPX breaking out above resistance, the one indicator that is giving you permission to do so is ...

This 'Mag 7' Stock Could Rise Another 21%, Says Bank of America

Apple (AAPL), valued at $2.9 trillion, remains one of the world’s most influential and highly appreciated companies. Known for its innovative products, robust ecosystem, ...

New Analysts Initiate Coverage: 3 Stocks to Add to Your Portfolio

The initiation of coverage by new analysts can be highly advantageous for investors and has a substantial impact on financial markets. Analysts typically possess ...

The Return of Meme Stock Mania? 3 Names to Bet On Now

Earlier last week, investor Keith Gill, better known as Roaring Kitty, returned to X, the social media platform formerly called Twitter. Roaring Kitty was ...

Why Is GT Biopharma (GTBP) Stock Up 143% Today?

Source: shutterstock.com/Romix Image GT Biopharma (NASDAQ:GTBP) stock is soaring higher on Monday alongside heavy pre-market trading of the clinical-stage biopharmaceutical company’s shares. This has more ...

Zacks Initiates Coverage of Investors Title With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Investors Title Company ITIC with a “Neutral” recommendation. The company’s performance and growth potential are compelling, ...